Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Recruiting

Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.

NCT06660446

Conditions: Behavior, Fatigue, Hemic and Lymphatic Diseases, +10 more
Locations: Hospital Universitario Araba (HUA) Vitoria - Gateiz, Araba, Spain

Hospital Universitario Galdakao (HUG) Galdakao, Bizkaia, Spain

Hospital Universitario Donostia (HUD) San Sebastián, Guipuzcoa, Spain

View Trial Details

Recruiting

Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma

NCT06826118

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Bing Xu Xiamen, Fujian, China

View Trial Details

Recruiting

Italian Study of Patients With Lymphoma

NCT06814925

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy

View Trial Details

Recruiting

Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET

NCT05654675

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations: Academisch ziekenhuis Maastricht Maastricht, Limburg, Netherlands

View Trial Details

Recruiting

Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma

NCT06795113

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma

NCT05341557

Conditions: Advanced Solid Tumor, HCC, Hemic and Lymphatic Diseases, +8 more
Locations: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Chaoyang, Beijing Municipality, China

Cangzhou Central Hospital Cangzhou, Hebei, China

Tianjin Cancer Hospital Tianjin, Tianjin Municipality, China

Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia

NCT06307600

Conditions: B Lymphoblastic Leukemia/Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: Anhui Provincial Hospital Hefei, Anhui, China

Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

NCT06781437

Conditions: Autoimmune Diseases, Autoimmune Lymphoproliferative Syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations: IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy

View Trial Details

Recruiting

Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines

NCT06774326

Conditions: Cardiac Imaging, Cardiac Imaging Techniques, Hemic and Lymphatic Diseases, +8 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Recruiting

A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy

NCT06756321

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Affiliated Hospital of Nantong University Nantong, Jiangsu, China

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions